Literature DB >> 10965469

Regulation and expression of metazoan unconventional myosins.

A M Sokac1, W M Bement.   

Abstract

Unconventional myosins are molecular motors that convert adenosine triphosphate (ATP) hydrolysis into movement along actin filaments. On the basis of primary structure analysis, these myosins are represented by at least 15 distinct classes (classes 1 and 3-16), each of which is presumed to play a specific cellular role. However, in contrast to the conventional myosins-2, which drive muscle contraction and cytokinesis and have been studied intensively for many years in both uni- and multicellular organisms, unconventional myosins have only been subject to analysis in metazoan systems for a short time. Here we critically review what is known about unconventional myosin regulation, function, and expression. Several points emerge from this analysis. First, in spite of the high relative conservation of motor domains among the myosin classes, significant differences are found in biochemical and enzymatic properties of these motor domains. Second, the idea that characteristic distributions of unconventional myosins are solely dependent on the myosin tail domain is almost certainly an oversimplification. Third, the notion that most unconventional myosins function as transport motors for membranous organelles is challenged by recent data. Finally, we present a scheme that clarifies relationships between various modes of myosin regulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10965469     DOI: 10.1016/s0074-7696(00)00005-x

Source DB:  PubMed          Journal:  Int Rev Cytol        ISSN: 0074-7696


  13 in total

1.  Myo1c binds phosphoinositides through a putative pleckstrin homology domain.

Authors:  David E Hokanson; Joseph M Laakso; Tianming Lin; David Sept; E Michael Ostap
Journal:  Mol Biol Cell       Date:  2006-09-13       Impact factor: 4.138

Review 2.  A millennial myosin census.

Authors:  J S Berg; B C Powell; R E Cheney
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

3.  Myr 8, a novel unconventional myosin expressed during brain development associates with the protein phosphatase catalytic subunits 1alpha and 1gamma1.

Authors:  K G Patel; C Liu; P L Cameron; R S Cameron
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

4.  Myosin-1c couples assembling actin to membranes to drive compensatory endocytosis.

Authors:  Anna M Sokac; Cataldo Schietroma; Cameron B Gundersen; William M Bement
Journal:  Dev Cell       Date:  2006-11       Impact factor: 12.270

5.  Human Myo19 is a novel myosin that associates with mitochondria.

Authors:  Omar A Quintero; Melinda M DiVito; Rebecca C Adikes; Melisa B Kortan; Lindsay B Case; Audun J Lier; Niki S Panaretos; Stephanie Q Slater; Michelle Rengarajan; Marianela Feliu; Richard E Cheney
Journal:  Curr Biol       Date:  2009-11-26       Impact factor: 10.834

6.  A role for myosin 1e in cortical granule exocytosis in Xenopus oocytes.

Authors:  Cataldo Schietroma; Hoi-Ying Yu; Mark C Wagner; Joy A Umbach; William M Bement; Cameron B Gundersen
Journal:  J Biol Chem       Date:  2007-08-16       Impact factor: 5.157

Review 7.  Unconventional myosins acting unconventionally.

Authors:  Sarah Woolner; William M Bement
Journal:  Trends Cell Biol       Date:  2009-05-04       Impact factor: 20.808

8.  Myo1c binds tightly and specifically to phosphatidylinositol 4,5-bisphosphate and inositol 1,4,5-trisphosphate.

Authors:  David E Hokanson; E Michael Ostap
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

9.  Trifluoperazine inhibits the MgATPase activity and in vitro motility of conventional and unconventional myosins.

Authors:  James R Sellers; Fei Wang; Peter D Chantler
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

10.  Multiple myosins are required to coordinate actin assembly with coat compression during compensatory endocytosis.

Authors:  Hoi-Ying E Yu; William M Bement
Journal:  Mol Biol Cell       Date:  2007-08-15       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.